Thursday, 20 December 2018

AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies

British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials.


No comments:

Post a Comment